Data Collective Iv Gp, LLC has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $83.3 Million distributed in 6 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Recursion Pharmaceuticals, Inc. with a value of $44.6M, Evolv Technologies Holdings, Inc. with a value of $24.7M, Rocket Lab Usa, Inc. with a value of $14.1M, Roivant Sciences Ltd. with a value of $40K, and Mind Medicine (Mind Med) Inc. with a value of $0.

Examining the 13F form we can see an decrease of $31M in the current position value, from $114M to 83.3M.

Data Collective Iv Gp, LLC is based out at Palo Alto, CA

Below you can find more details about Data Collective Iv Gp, LLC portfolio as well as his latest detailed transactions.

Portfolio value $83.3 Million
Healthcare: $44.6 Million
Industrials: $38.7 Million
Financial Services: $0

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 6
  • Current Value $83.3 Million
  • Prior Value $114 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Data Collective Iv Gp, LLC Portfolio

Follow Data Collective Iv Gp, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Data Collective Iv Gp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Data Collective Iv Gp, LLC with notifications on news.